Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

IQVIA Holdings stock

IQV
US46266C1053
A2JSPM

Price

204.28
Today +/-
+4.97
Today %
+2.59 %

IQVIA Holdings stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the IQVIA Holdings stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the IQVIA Holdings stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the IQVIA Holdings stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze IQVIA Holdings's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

IQVIA Holdings Stock Price History

DateIQVIA Holdings Price
12/13/2024204.28 undefined
12/13/2024199.06 undefined
12/12/2024200.37 undefined
12/11/2024201.07 undefined
12/10/2024203.20 undefined
12/9/2024206.44 undefined
12/6/2024202.63 undefined
12/5/2024199.93 undefined
12/4/2024203.17 undefined
12/3/2024200.58 undefined
12/2/2024201.79 undefined
11/29/2024200.84 undefined
11/27/2024201.43 undefined
11/26/2024201.23 undefined
11/25/2024204.02 undefined
11/22/2024201.82 undefined
11/21/2024197.60 undefined
11/20/2024194.38 undefined
11/19/2024191.33 undefined
11/18/2024191.04 undefined
11/15/2024192.68 undefined

IQVIA Holdings Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into IQVIA Holdings, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by IQVIA Holdings from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects IQVIA Holdings’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of IQVIA Holdings. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into IQVIA Holdings’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing IQVIA Holdings’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on IQVIA Holdings’s growth potential.

IQVIA Holdings Revenue, EBIT and net profit per share

DateIQVIA Holdings RevenueIQVIA Holdings EBITIQVIA Holdings Net Income
2029e21.32 B undefined0 undefined3.45 B undefined
2028e19.61 B undefined4.72 B undefined3.18 B undefined
2027e18.27 B undefined4.13 B undefined2.78 B undefined
2026e17.24 B undefined3.5 B undefined2.47 B undefined
2025e16.29 B undefined3.26 B undefined2.21 B undefined
2024e15.53 B undefined3.15 B undefined2.04 B undefined
202314.98 B undefined2.06 B undefined1.36 B undefined
202214.41 B undefined1.83 B undefined1.09 B undefined
202113.87 B undefined1.41 B undefined966 M undefined
202011.36 B undefined783 M undefined279 M undefined
201911.09 B undefined852 M undefined191 M undefined
201810.41 B undefined809 M undefined259 M undefined
20179.7 B undefined768 M undefined1.28 B undefined
20166.82 B undefined762 M undefined72 M undefined
20155.74 B undefined680 M undefined387 M undefined
20145.46 B undefined599 M undefined356 M undefined
20135.1 B undefined477 M undefined227 M undefined
20124.87 B undefined415 M undefined178 M undefined
20114.33 B undefined380 M undefined242 M undefined
20103.92 B undefined421 M undefined161 M undefined
20093.9 B undefined431 M undefined210 M undefined
20083.76 B undefined318 M undefined35 M undefined

IQVIA Holdings Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)NET INCOME (B)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e2029e
3.763.93.924.334.875.15.465.746.829.710.4111.0911.3613.8714.4114.9815.5316.2917.2418.2719.6121.32
-3.670.6210.3012.434.817.065.0918.7742.367.326.492.4422.143.863.983.664.865.816.027.338.68
26.7728.6228.5226.3925.3426.2227.1427.9030.3335.0535.2134.1633.9733.4534.8934.9633.7332.1630.4028.6726.7124.58
1.011.121.121.141.231.341.481.62.073.43.673.793.864.645.035.24000000
0.040.210.160.240.180.230.360.390.071.280.260.190.280.971.091.362.042.212.472.783.183.45
-500.00-23.3350.31-26.4527.5356.838.71-81.401,673.61-79.72-26.2546.07246.2412.9424.4750.228.2411.8712.5514.328.50
116118118118118128131126152223208200195195191186.3000000
----------------------
Details

Keystats

ⓘ

Revenue and Growth

The IQVIA Holdings Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the IQVIA Holdings is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (B)GOODWILL (B)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (B)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (B)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (B)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
2011201220132014201520162017201820192020202120222023
                         
0.560.640.870.991.081.241.010.940.91.91.481.311.5
0.690.750.920.981.171.712.12.392.582.412.552.923.38
25181646343447695656584332
0000000000000
86110135140134358405473589722677712687
1.371.511.952.152.413.343.553.874.135.094.764.985.6
186194200190188406440434954953903863819
34556366858278142152162164162239
0000000000000
0.270.270.30.280.376.396.595.955.515.214.944.824.84
0.280.30.410.460.7210.7311.8511.812.1612.6513.313.9214.57
190165151149153266344348346500615590621
0.960.991.121.151.5117.8719.318.6819.1319.4719.9320.3621.09
2.322.53.073.33.9321.2122.8622.5523.2524.5624.6925.3426.68
                         
00.010.480.140.0110.60000000
00000010.7810.911.0511.0910.7710.911.03
-0.99-1.37-1.15-0.79-0.46-0.40.540.8111.282.243.334.69
237-6-59-111-57049-224-311-205-406-727-867
0060-100000000
-0.97-1.36-0.67-0.7-0.579.6311.3711.4811.7412.1712.6113.5114.85
7085101842145250322437575581621645709
0.620.660.7600.691.331.491.641.862.122.192.412.63
0.490.510.610.630.711.041.251.361.421.712.332.362.43
0000000000000
20561014992103100100149100157718
1.191.311.481.471.62.713.163.533.954.565.245.586.49
1.952.372.042.282.427.1110.1210.9111.5512.5112.2112.8213.18
0.010.010.040.060.072.130.90.740.650.340.410.460.2
139171179184183402440418852882785711693
2.12.552.252.532.679.6411.4612.0613.0413.7313.4113.9914.08
3.293.863.7444.2612.3514.6115.616.9918.2818.6519.5720.57
2.322.53.073.33.721.9825.9827.0828.7230.4531.2633.0835.42
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of IQVIA Holdings provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand IQVIA Holdings's financial health and stability.

Assets

IQVIA Holdings's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that IQVIA Holdings must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of IQVIA Holdings after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into IQVIA Holdings's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (B)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (B)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
nullnull20102011201220132014201520162017201820192020202120222023
000.170.240.180.230.360.390.091.30.280.230.310.971.091.36
000.090.090.10.110.120.130.291.011.141.21.291.261.131.13
00-9-7316-24-618115-1,221-177-157-176-138-115-269
00103-821256-45-69275-255-10619459680-84-280
0042-157503648174245225272176335432432
001381001271159382124320398421399343379556
00776310471138120106195211215209222255340
0.210.480.380.160.340.390.430.480.860.971.251.421.962.942.262.15
00-80-75-71-88-82-78-164-369-459-582-616-640-674-649
-0.1-0.09-0.14-0.22-0.13-0.24-0.17-0.071.73-1.19-0.81-1.19-0.8-2.1-2.01-1.6
00-0.06-0.15-0.06-0.15-0.090.011.9-0.82-0.35-0.61-0.18-1.46-1.33-0.95
0000000000000000
00-0.080.260.44-0.390.240.19-1.312.511.020.750.340.070.940.8
00-9-13-9480-388-450-1,000-2,529-1,390-938-491-465-1,239-1,053
-99-270-153-59-14671-130-249-2,284-72-452-276-217-1,235-329-382
002-17-9-21151429-54-77-85-68-840-31-131
00-67-288-56700000000000
0080-1305121089109221-239-68-54977-448-150160
0029885.3264.4305.1349.1397.36966017958351,3432,3021,5861,500
0000000000000000

IQVIA Holdings stock margins

The IQVIA Holdings margin analysis displays the gross margin, EBIT margin, as well as the profit margin of IQVIA Holdings. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for IQVIA Holdings.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the IQVIA Holdings's sales revenue. A higher gross margin percentage indicates that the IQVIA Holdings retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the IQVIA Holdings's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the IQVIA Holdings's total revenue generated. When comparing the revenue margin year over year, investors can gauge the IQVIA Holdings's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the IQVIA Holdings. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the IQVIA Holdings's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

IQVIA Holdings Margin History

IQVIA Holdings Gross marginIQVIA Holdings Profit marginIQVIA Holdings EBIT marginIQVIA Holdings Profit margin
2029e34.96 %0 %16.18 %
2028e34.96 %24.05 %16.21 %
2027e34.96 %22.61 %15.22 %
2026e34.96 %20.32 %14.33 %
2025e34.96 %20.04 %13.56 %
2024e34.96 %20.29 %13.14 %
202334.96 %13.75 %9.06 %
202234.89 %12.68 %7.57 %
202133.45 %10.18 %6.96 %
202033.97 %6.89 %2.46 %
201934.16 %7.68 %1.72 %
201835.21 %7.77 %2.49 %
201735.05 %7.92 %13.16 %
201630.33 %11.18 %1.06 %
201527.9 %11.85 %6.74 %
201427.14 %10.97 %6.52 %
201326.22 %9.35 %4.45 %
201225.34 %8.53 %3.66 %
201126.39 %8.78 %5.59 %
201028.52 %10.73 %4.1 %
200928.62 %11.05 %5.38 %
200826.77 %8.45 %0.93 %

IQVIA Holdings Stock Sales Revenue, EBIT, Earnings per Share

The IQVIA Holdings earnings per share therefore indicates how much revenue IQVIA Holdings has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue IQVIA Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates IQVIA Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of IQVIA Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating IQVIA Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

IQVIA Holdings Revenue, EBIT and net profit per share

DateIQVIA Holdings Sales per ShareIQVIA Holdings EBIT per shareIQVIA Holdings Earnings per Share
2029e117.44 undefined0 undefined19 undefined
2028e108.06 undefined0 undefined17.51 undefined
2027e100.68 undefined0 undefined15.32 undefined
2026e94.96 undefined0 undefined13.61 undefined
2025e89.74 undefined0 undefined12.17 undefined
2024e85.58 undefined0 undefined11.24 undefined
202380.43 undefined11.06 undefined7.29 undefined
202275.45 undefined9.57 undefined5.71 undefined
202171.15 undefined7.25 undefined4.95 undefined
202058.25 undefined4.02 undefined1.43 undefined
201955.44 undefined4.26 undefined0.96 undefined
201850.06 undefined3.89 undefined1.25 undefined
201743.51 undefined3.44 undefined5.73 undefined
201644.84 undefined5.01 undefined0.47 undefined
201545.54 undefined5.4 undefined3.07 undefined
201441.68 undefined4.57 undefined2.72 undefined
201339.84 undefined3.73 undefined1.77 undefined
201241.24 undefined3.52 undefined1.51 undefined
201136.68 undefined3.22 undefined2.05 undefined
201033.25 undefined3.57 undefined1.36 undefined
200933.05 undefined3.65 undefined1.78 undefined
200832.43 undefined2.74 undefined0.3 undefined

IQVIA Holdings business model

IQVIA Holdings Inc is a global company specializing in providing data, technology, and services in the healthcare sector. It is headquartered in Durham, North Carolina and employs more than 70,000 employees in over 100 countries worldwide. The company was formed in 2017 as an official merger between IMS Health and Quintiles Transnational, both of which have a long history in the healthcare industry. IQVIA offers a wide range of products and services to support companies in making informed decisions and successfully bringing their products to market. This includes clinical research services, data analysis, real-world evidence collection and analysis, commercialization services, and technology solutions. IQVIA operates in five main divisions: clinical and contract research, real world solutions, commercial solutions, IQVIA technologies, and digital applications. The company is known for its high standards of quality and data security, and aims to drive innovation in the healthcare industry. IQVIA Holdings is one of the most popular companies on Eulerpool.com.

IQVIA Holdings SWOT Analysis

Strengths

1. Diverse Portfolio: IQVIA Holdings Inc offers a wide range of healthcare and pharmaceutical services, including clinical trial management, data analytics, and consulting.

2. Strong Global Presence: With operations in over 100 countries, IQVIA has established a strong international market presence, allowing it to serve clients worldwide.

3. Technological Advancements: The company leverages innovative technologies, such as artificial intelligence and cloud computing, to drive efficiency and improve its service offerings.

Weaknesses

1. Dependency on Key Clients: IQVIA relies heavily on a few large pharmaceutical companies for a significant portion of its revenue, making it vulnerable to changes in client relationships.

2. Regulatory Challenges: The healthcare industry is subject to strict regulations and compliance requirements, which can pose challenges for IQVIA in terms of navigating complex regulatory frameworks.

3. Limited Product Differentiation: Some of IQVIA's services may face competition from similar offerings in the market, making it important for the company to continuously innovate and differentiate itself.

Opportunities

1. Growing Healthcare Industry: The increasing importance of healthcare services presents opportunities for IQVIA to expand its client base and offer its expertise in an evolving market.

2. Emerging Markets: IQVIA can tap into the potential of emerging markets, particularly in Asia and Latin America, where healthcare spending and demand for pharmaceutical services are on the rise.

3. Data Analytics Potential: The increasing availability and relevance of data in the healthcare industry provide IQVIA with opportunities to leverage its data analytics capabilities and offer valuable insights to clients.

Threats

1. Economic Uncertainty: Changes in global economic conditions and financial instability can affect healthcare spending, potentially impacting IQVIA's revenue and growth prospects.

2. Competitive Landscape: The healthcare and pharmaceutical services industry is highly competitive, with the presence of both established players and new entrants, which may pose challenges for IQVIA.

3. Data Security Risks: As IQVIA deals with sensitive healthcare data, it faces the ongoing challenge of ensuring data privacy and protection against cyber threats and breaches.

IQVIA Holdings Revenue by Segment

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

IQVIA Holdings Revenue by Segment

Segmente202320222021202020192018
Research & Development Solutions8.4 B USD7.92 B USD7.56 B USD5.76 B USD--
Technology & Analytics Solutions5.86 B USD5.75 B USD5.53 B USD4.86 B USD--
Research and development solutions----5.79 B USD5.47 B USD
Technology and analytics solutions----4.49 B USD4.14 B USD
Contract Sales & Medical Solutions727 M USD743 M USD784 M USD741 M USD--
Contract sales and medical solutions----814 M USD810 M USD

IQVIA Holdings Revenue by Region

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

IQVIA Holdings Revenue by Segment

DateAmericasAsia-PacificEurope and Africa
20237.55 B USD2.97 B USD4.46 B USD
20227.05 B USD3 B USD4.37 B USD
20216.85 B USD2.67 B USD4.36 B USD
20205.42 B USD2.25 B USD3.7 B USD
20195.46 B USD2.15 B USD3.48 B USD
20185 B USD1.97 B USD3.45 B USD
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

IQVIA Holdings Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

IQVIA Holdings historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

IQVIA Holdings shares outstanding

The number of shares was IQVIA Holdings in 2023 — This indicates how many shares 186.3 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue IQVIA Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates IQVIA Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of IQVIA Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating IQVIA Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for IQVIA Holdings.

IQVIA Holdings latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20242.84 2.84  (0.06 %)2024 Q3
6/30/20242.59 2.64  (1.9 %)2024 Q2
3/31/20242.51 2.54  (1.39 %)2024 Q1
12/31/20232.85 2.84  (-0.32 %)2023 Q4
9/30/20232.47 2.49  (0.87 %)2023 Q3
6/30/20232.4 2.43  (1.45 %)2023 Q2
3/31/20232.43 2.45  (0.72 %)2023 Q1
12/31/20222.79 2.78  (-0.34 %)2022 Q4
9/30/20222.41 2.48  (2.96 %)2022 Q3
6/30/20222.4 2.44  (1.46 %)2022 Q2
1
2
3
4
...
5

Eulerpool ESG Scorecard© for the IQVIA Holdings stock

Eulerpool World ESG Rating (EESG©)

69/ 100

🌱 Environment

56

👫 Social

99

🏛️ Governance

50

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees61
Percentage of women in management
Percentage of Asian employees16
Share of Asian management
Percentage of Hispanic/Latino employees8
Hispano/Latino Management share
Percentage of Black employees12
Black Management Share
Percentage of white employees61
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

IQVIA Holdings shareholders

%
Name
Stocks
Change
Date
11.13268 % The Vanguard Group, Inc.20,205,818-784,9346/30/2024
5.87950 % Harris Associates L.P.10,671,294527,9066/30/2024
5.68455 % BlackRock Institutional Trust Company, N.A.10,317,462-532,6696/30/2024
5.03058 % GIC Private Limited9,130,4969,130,4968/13/2024
4.42321 % State Street Global Advisors (US)8,028,11966,0766/30/2024
2.32617 % Geode Capital Management, L.L.C.4,221,99166,0486/30/2024
2.21666 % AllianceBernstein L.P.4,023,229-200,3346/30/2024
1.87520 % CPP Investment Board3,403,488211,6536/30/2024
1.81185 % Lazard Asset Management, L.L.C.3,288,51524,5716/30/2024
1.61049 % Farallon Capital Management, L.L.C.2,923,03286,8706/30/2024
1
2
3
4
5
...
10

IQVIA Holdings Executives and Management Board

Mr. Ari Bousbib

(61)
IQVIA Holdings Chairman of the Board, Chief Executive Officer (since 2016)
Compensation 30.14 M

Mr. Ronald Bruehlman

(62)
IQVIA Holdings Chief Financial Officer, Executive Vice President
Compensation 8.62 M

Mr. Eric Sherbet

(58)
IQVIA Holdings Executive Vice President, General Counsel, Secretary
Compensation 3.62 M

Mr. Walter Staub

(60)
IQVIA Holdings President - Research and Development Solutions
Compensation 3.56 M

Mr. Kevin Knightly

(62)
IQVIA Holdings President - Corporate Strategy and Enterprise Networks
Compensation 3.41 M
1
2
3

IQVIA Holdings Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Hewlett Packard Enterp Stock
Hewlett Packard Enterp
SupplierCustomer0,760,590,18-0,37-0,350,82
BrainPad Stock
BrainPad
SupplierCustomer0,550,880,420,720,560,30
Diversified Healthcare Tr Stock
Diversified Healthcare Tr
SupplierCustomer0,470,880,320,170,16-0,45
Corcept Therapeutics Incorporated Stock
Corcept Therapeutics Incorporated
SupplierCustomer0,380,86-0,07-0,48-0,450,19
Catalent, Inc. Stock
Catalent, Inc.
SupplierCustomer0,350,740,500,860,740,79
Quest Diagnostics Stock
Quest Diagnostics
SupplierCustomer0,350,51-0,070,800,740,87
NRX Pharmaceuticals Stock
NRX Pharmaceuticals
SupplierCustomer0,350,79-0,050,770,19
Dimerix Stock
Dimerix
SupplierCustomer0,160,840,320,650,56-0,46
Vericel Corporation Stock
Vericel Corporation
SupplierCustomer0,160,810,430,540,210,71
Anthem Stock
Anthem
SupplierCustomer0,160,690,20-0,50-0,340,82
1

Most common questions regarding IQVIA Holdings

What values and corporate philosophy does IQVIA Holdings represent?

IQVIA Holdings Inc is known for its strong values and corporate philosophy. The company emphasizes innovation, integrity, and collaboration. With a commitment to advancing healthcare, IQVIA strives to improve patient outcomes and support the life sciences industry. By combining cutting-edge technology, data analytics, and deep industry expertise, IQVIA delivers actionable insights and solutions to its clients. The company's dedication to ethical practices, global impact, and teamwork sets it apart in the market. IQVIA Holdings Inc continuously works towards transforming healthcare through its core values and corporate philosophy.

In which countries and regions is IQVIA Holdings primarily present?

IQVIA Holdings Inc is primarily present in various countries and regions across the globe. As a leading provider of advanced analytics, technology solutions, and clinical research services, IQVIA operates in more than 100 countries worldwide. With a strong presence in North America, Europe, Asia-Pacific, and the Middle East, IQVIA caters to the needs of pharmaceutical, biotechnology, and healthcare companies across these regions. The company's extensive global reach positions it well to support and collaborate with clients on a global scale.

What significant milestones has the company IQVIA Holdings achieved?

IQVIA Holdings Inc has achieved several significant milestones in its history. One notable achievement is the merger between IMS Health and Quintiles Transnational in 2016, which led to the formation of IQVIA. This merger created a leading global provider of advanced analytics, technology solutions, and contract research services to the healthcare industry. Another milestone is the company's consistent focus on innovation and cutting-edge research. IQVIA has pioneered groundbreaking solutions in areas such as real-world evidence, patient centricity, and digital health. Additionally, IQVIA has expanded its global footprint and established a strong presence in key markets worldwide. These achievements have solidified IQVIA Holdings Inc as a frontrunner in the healthcare and life sciences industry.

What is the history and background of the company IQVIA Holdings?

IQVIA Holdings Inc, formerly known as Quintiles IMS Holdings Inc, is a leading global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry. The company was formed in 2016 through the merger of Quintiles Transnational Holdings Inc and IMS Health Holdings Inc. With a history dating back to 1982, IQVIA has been at the forefront of transforming the way pharmaceutical, biotechnology, and healthcare companies operate. Today, IQVIA leverages its extensive data, domain expertise, and innovative technologies to improve clinical trial outcomes, enhance real-world evidence solutions, and drive healthcare intelligence for its clients.

Who are the main competitors of IQVIA Holdings in the market?

The main competitors of IQVIA Holdings Inc in the market include companies such as LabCorp, PRA Health Sciences, ICON PLC, and Syneos Health.

In which industries is IQVIA Holdings primarily active?

IQVIA Holdings Inc is primarily active in the healthcare and pharmaceutical industries. With its comprehensive range of services and solutions, IQVIA plays a crucial role in supporting the advancement of healthcare worldwide. As a leading provider of integrated information and technology-enabled solutions, IQVIA assists pharmaceutical companies, healthcare providers, and researchers in optimizing their operations and making informed decisions. With its vast expertise and global presence, IQVIA continues to drive innovation, improve patient outcomes, and contribute to the overall growth and development of the healthcare industry.

What is the business model of IQVIA Holdings?

The business model of IQVIA Holdings Inc is focused on providing advanced analytics, technology solutions, and contract research services to the life sciences industry. IQVIA offers a wide range of services, including clinical trial support, real-world evidence solutions, commercial effectiveness, and healthcare data management. Through leveraging its vast network of healthcare professionals and extensive data resources, IQVIA helps pharmaceutical, biotech, and medical device companies navigate the complex healthcare landscape, drive innovation, and improve patient outcomes.

What is the P/E ratio of IQVIA Holdings 2024?

The IQVIA Holdings P/E ratio is 18.65.

What is the P/S ratio of IQVIA Holdings 2024?

The IQVIA Holdings P/S ratio is 2.45.

What is the Quality Investing of IQVIA Holdings?

The Quality Investing for IQVIA Holdings is 7/10.

What is the revenue of IQVIA Holdings 2024?

The expected IQVIA Holdings revenue is 15.53 B USD.

How high is the profit of IQVIA Holdings 2024?

The expected IQVIA Holdings profit is 2.04 B USD.

What is the business model of IQVIA Holdings

IQVIA Holdings Inc. is a global leader in the healthcare industry. It combines biomedical insights in innovative ways to improve global health. IQVIA offers various divisions, including research and analysis solutions, technology platforms, clinical development, and commercial support. Its mission is to enhance patient care while reducing healthcare costs. The company provides a wide range of products and services tailored to customer needs, with the overarching goal of improving patient outcomes worldwide.

What is the IQVIA Holdings dividend?

IQVIA Holdings pays a dividend of 0 USD distributed over payouts per year.

How often does IQVIA Holdings pay dividends?

The dividend cannot currently be calculated for IQVIA Holdings or the company does not pay out a dividend.

What is the IQVIA Holdings ISIN?

The ISIN of IQVIA Holdings is US46266C1053.

What is the IQVIA Holdings WKN?

The WKN of IQVIA Holdings is A2JSPM.

What is the IQVIA Holdings ticker?

The ticker of IQVIA Holdings is IQV.

How much dividend does IQVIA Holdings pay?

Over the past 12 months, IQVIA Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, IQVIA Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of IQVIA Holdings?

The current dividend yield of IQVIA Holdings is .

When does IQVIA Holdings pay dividends?

IQVIA Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of IQVIA Holdings?

IQVIA Holdings paid dividends every year for the past 0 years.

What is the dividend of IQVIA Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is IQVIA Holdings located?

IQVIA Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von IQVIA Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of IQVIA Holdings from 12/14/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/14/2024.

When did IQVIA Holdings pay the last dividend?

The last dividend was paid out on 12/14/2024.

What was the dividend of IQVIA Holdings in the year 2023?

In the year 2023, IQVIA Holdings distributed 0 USD as dividends.

In which currency does IQVIA Holdings pay out the dividend?

The dividends of IQVIA Holdings are distributed in USD.

All fundamentals about IQVIA Holdings

Our stock analysis for IQVIA Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of IQVIA Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.